Underpinning Voyager’s mission is its trademark AAV capsid-discovery platform ... GCase in multiple brain regions in mouse models, following a single IV dose. As GCase-activity increases ...

“exhibits potent editing capabilities across various cell systems and tissues in vivo when administered via adeno-associated viral (AAV) vectors.” When targeting the PCSK9 gene in mouse liver ...